Neuropace Inc
Change company Symbol lookup
Select an option...
NPCE Neuropace Inc
ESUS ETRACS 2x Leveraged MSCI USA ESG Focus TR ETN
BSRR Sierra Bancorp
CO Global Cord Blood Corp
AHT-G Ashford Hospitality Trust Inc
LUVU Luvu Brands Inc
MYD BlackRock MuniYield
NMG Nouveau Monde Graphite Inc
VLYPO Valley National Bancorp
PEPL PepperLime Health Acquisition Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

NeuroPace, Inc. is a commercial-stage medical device company. The Company is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.

Closing Price
$3.75
Day's Change
0.25 (7.14%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.83
Day's Low
3.44
Volume
(Heavy Day)
Volume:
75,703

10-day average volume:
26,964
75,703

Company Profile

NeuroPace, Inc. is a commercial-stage medical device company. The Company is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
1.84x
Price/Book (MRQ)
1.49x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

September 2022
Current Month
621.5K
Previous Month
628.1K
Percent of Float
3.60%
Days to Cover
20.9166 Days

Share Information

NPCE is in a share class of common stock
Float
21.5M
Shares Outstanding
24.8M
Institutions Holding Shares
44
82.76%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Frank M. FischerChmn.
  • Michael FavetPres.
  • Rebecca L. KuhnCFO
  • Irina RidleyCounsel
  • Martha J. MorrellOther

Address

Insider Trading

During the most recent quarter, 3K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.